Clinical Trial Update: Trial Assessing Zactima Against Placebo in Prostate Cancer Subjects Undergoing Intermittent Androgen Deprivation Hormonal Therapy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Zactima (vandetanib) versus placebo in prostate cancer patients on intermittent androgen deprivation therapy was terminated; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Zactima (vandetanib)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2011-05-24